MDT Medtronic
WatchlistMedtronic News
Are Investors Overreacting on AtriCure After Medtronic's Penditure Launch?
Medtronic Reports First Patient Treated With Symplicity Spyral Renal Denervation System
AtriCure Defended at UBS Despite Medtronic's Rival Product
Medtronic Stock: Bull Vs. Bear
Needham Says Medtronic Could Create Overhang on AtriCure Shares
Needham Says Medtronic Initiation Of Limited US Release Of Left Atrial Appendage Exclusion System Could Create Overhang For AtriCure
Needham Says Medtronic Initiation Of Limited US Release Of Left Atrial Appendage Exclusion System Could Create Overhang For AtriCure
'Medtronic to Chase Boston Scientific, Abbott in Left Atrial Appendage Closure Market' -MedTech Dive
'Medtronic to Chase Boston Scientific, Abbott in Left Atrial Appendage Closure Market' -MedTech Dive
Medtronic LABS: Opening Up Software To Expand Access to Healthcare
NORTHAMPTON, MA / ACCESSWIRE / November 28, 2023 / MedtronicMedtronic LABS makes its digital health platform open sourceMedtronic LABS accelerates access to healthcare in underserved communities aroun
Global Disposable Surgical Devices Market Share & Trends Report 2023-2030 Featuring B. Braun, Smith+Nephew, Aspen, Alcon, Zimmer Biomet, Medtronic, BD, Ethicon, CooperSurgical, Surgical Innovations - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Disposable Surgical Devices Market Size, Share & Trends Analysis Report By Product (Surgical Sutures & Staplers, Electrosurgical devices), By Application (General Surgery
Medtronic to Chase Boston Scientific, Abbott in Left Atrial Appendage Closure Market
Medtronic Launches Left Atrial Appendage Exclusion System
President Biden to Use 1950 Law to Boost Essential Drug Production
What's Next for Medtronic's RDN Program After FDA Approval
Analysts' Top Healthcare Picks: Medtronic (MDT), Sanofi (SNYNF)
Changes in Hong Kong stocks | Baixinan-B (02185) rose nearly 7% Medtronic RDN products were approved in the US, and the company's RDN products are progressing ahead in China
Baixinan-B (02185) rose nearly 7%. As of press release, it was up 6.99% to HK$4.44, with a turnover of HK$1,218,000.
After more than ten years of experience, Medtronic RDN was approved to begin commercialization
Compared to other Red Sea markets, this RDN circuit, which is still in the Blue Ocean market, not only has global medical device giants betting, but also many excellent domestic local companies struggling to catch up.
Is Medtronic a Good Dividend Stock to Buy Now?
Unusual Options Activity: TFC, TSLA and Others Attract Market Bets, TFC V/OI Ratio Reaches 46.6
EST Nov 22nd Morning Delivery - In the last 2 hours of trading, 7 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.Of
RBC Capital Reiterates Sector Perform on Medtronic, Maintains $82 Price Target
RBC Capital analyst Shagun Singh reiterates Medtronic (NYSE:MDT) with a Sector Perform and maintains $82 price target.
Deutsche Bank Adjusts Medtronic Price Target to $79 From $87, Maintains Hold Rating
Medtronic (MDT) has an average rating of outperform and price targets ranging from $68 to $112, according to analysts polled by Capital IQ. Price: 78.27, Change: -0.35, Percent Change: -0.45